The FY2025 (Dec) proxy of Amneal Pharmaceuticals names 14 peer companies for pay. Pay versus performance data of Amneal Pharmaceuticals for that year is not on file, so it has no rank.
Pay peer group, FY2025 (Dec) proxy
| Teva Pharmaceutical Industries | ||
| United Therapeutics | ||
| Supernus Pharmaceuticals | ||
| Viatris | ||
| PERRIGO Co | ||
| Alkermes plc. | ||
| Neurocrine Biosciences | ||
| Prestige Consumer Healthcare | ||
| Organon & Co. | ||
| Ani Pharmaceuticals | Not disclosed | Not disclosed |
| Amphastar Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| Emergent BioSolutions Inc. | Not disclosed | Not disclosed |
| Jazz Pharmaceuticals | Not disclosed | Not disclosed |
| Pacira BioSciences, Inc. | Not disclosed | Not disclosed |
14 companies
Changes by year
FY2025 (Dec) proxy
- RemovedCoherus BioSciences, Inc.pay peer groupfollowing consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2024 compensation peer group, along with the recommendation of its independent compensation consultant, the Compensation Committee removed Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc. and Horizon Therapeutics Public Limited Company from our peer group
- RemovedEagle Pharmaceuticals, Inc.pay peer groupfollowing consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2024 compensation peer group, along with the recommendation of its independent compensation consultant, the Compensation Committee removed Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc. and Horizon Therapeutics Public Limited Company from our peer group
- RemovedHorizon Therapeutics Public Limited Companypay peer groupfollowing consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2024 compensation peer group, along with the recommendation of its independent compensation consultant, the Compensation Committee removed Coherus BioSciences, Inc., Eagle Pharmaceuticals, Inc. and Horizon Therapeutics Public Limited Company from our peer group
FY2024 (Dec) proxy
- RemovedEndo Internationalpay peer groupIn consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2023 compensation peer group, along with the recommendation of its independent compensation consultant, in August 2023, the Compensation Committee removed Endo International, Lannett Company, and Mallinckrodt plc from our peer group, which was used for purposes of evaluating 2024 compensation decisions
- RemovedLannett Companypay peer groupIn consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2023 compensation peer group, along with the recommendation of its independent compensation consultant, in August 2023, the Compensation Committee removed Endo International, Lannett Company, and Mallinckrodt plc from our peer group, which was used for purposes of evaluating 2024 compensation decisions
- RemovedMallinckrodt plcpay peer groupIn consideration of these factors, as well as the financial restructuring efforts undertaken by certain of the companies included in our 2023 compensation peer group, along with the recommendation of its independent compensation consultant, in August 2023, the Compensation Committee removed Endo International, Lannett Company, and Mallinckrodt plc from our peer group, which was used for purposes of evaluating 2024 compensation decisions
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.